‘Exciting' new diagnostic method can detect tiny traces of cancer
Usual tests include blood tests and bone marrow biopsies, CT scans and X rays.
Experts said that this scanning technique can provide an important insight into how well patients are responding to treatment and whether they might relapse.
Myeloma is a type of blood cancer that develops from plasma cells in the bone marrow.
The condition is sometimes called multiple myeloma because it affects more than one part of the body.
The disease is not considered curable but treatment can control it.
Researchers at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, tracked 70 myeloma patients who were having a stem cell transplant.
1/2 Many people living with myeloma experience symptoms for months or even years before receiving a diagnosis.
By sharing this post, you can help raise awareness and make sure more people recognise the warning signs sooner ⚠️ #MyelomaAwarenessWeek #MyelomaWarningSigns pic.twitter.com/hgQTVM5RW0
— Myeloma UK (@MyelomaUK) June 16, 2025
They were all given a whole-body MRI before and after the treatment.
Writing in the Blood Cancer Journal, experts said that one in three patients had signs of residual disease on whole-body MRI after treatment – which can be given to patients without the use of radiation.
Overall survival was also significantly shorter in those with positive MRI findings.
The Royal Marsden has already adopted the the whole-body imagine technique and it could help shape cancer care for patients around the country in the future.
One patient under the treatment of the hospital described how the scanning technique 'extended his life' and enabled him to 'continue serving' the country.
Air Vice-Marshal Fin Monahan, chief fire officer for South Wales Fire and Rescue Service, was diagnosed with myeloma in 2009 while serving in the RAF.
He has since relapsed twice, but thanks to whole-body MRI scans, his cancer was detected much earlier than would have been possible with a traditional CT scan.
The father of three, 57, said: 'With the constant threat of relapse, myeloma patients are in a long-term mental battle with this insidious disease.
'However, being part of the whole-body MRI scan study at the Royal Marsden allowed my cancer to be closely watched and resulted in me being treated sooner than I would have been under normal protocols.
'This not only extended my life but after diagnosis, I returned to flying jets and to active operational duties.
'I would eventually not be allowed to fly on medical grounds due to myeloma but paved the way to establishing the first training programme of Ukrainian forces in 2015 and I was called upon to run Nato air operations after the invasion of Ukraine.
'This cutting-edge treatment not only extended my life but allowed me to continue serving my country.'
Study chief investigator, Professor Christina Messiou, consultant radiologist at The Royal Marsden NHS Foundation Trust, and professor in imaging for personalised oncology at The Institute of Cancer Research, said: 'This study shows that whole-body MRI gives us valuable information about how well the myeloma has responded to treatment that other tests may miss.
'It's exciting that we now have a standardised, non-invasive imaging method that can be used across cancer centres.
'Whole-body MRI doesn't involve radiation or intravenous injections, which is important for patients who may require lifelong monitoring.
'This is an important step towards smarter and kinder precision diagnostics for patients with cancer'
Professor Martin Kaiser, consultant haematologist at The Royal Marsden NHS Foundation Trust and professor in molecular haematology at The Institute of Cancer Research, London, added: 'Access to this gold-standard precision imaging with whole-body MRI has revolutionised care for myeloma patients.
'As the treatment options for myeloma increase and factors such as disease distribution across the body are increasingly understood as important to treatment response, the relevance of the whole-body MRI for personalising treatment will only increase over time.'
Around 6,200 people are diagnosed with the condition each year in the UK and charity Myeloma UK estimates that there are around 33,000 people living with myeloma in the UK.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
8 hours ago
- BBC News
Dudley's Russells Hall Hospital uses AI to help stroke patients
Stroke patients at a hospital are receiving a faster diagnosis with the help of artificial intelligence (AI) Hall Hospital in Dudley introduced RapidAI into its stroke unit in May 2024, with the technology speeding up the triage process for patients by providing instant access to diagnostic minister Stephen Kinnock visited the hospital on Tuesday, where he saw the "potentially life-saving improvement" in of the latest patients to benefit is Patrick Potter from Stourbridge, who had a stroke on Thursday and suffered a bleed on the brain. Mr Potter's scan was sent straight to his consultant's mobile phone, resulting in quicker diagnosis and treatment - and with a stroke, doctors say every minute 62-year-old said the technology was "absolutely brilliant"."I don't know to what extent or what damage it would have done to my brain," he said."Initially I was terrified because I've never had anything happen like that before, but within a few days [I was told] it looks like it'll be able to recover and you'll be okay." While visiting the hospital on Tuesday, Kinnock said: "Within seconds of the scan taking place, the consultants are able to see exactly what the issue is in terms of what has caused the stroke."That speed of information is then shared through an app with all the relevant consultants, the quicker they get the diagnosis, the quicker they can decide what treatment is required."He added: "This use of AI can slash the time between someone showing symptoms of stroke to getting treatment by up to an hour – a potentially life-saving improvement. When it comes to strokes, every second counts." Diagnosis within an hour The technology speeds up the triage process by providing instant access to diagnostic imaging, accompanied by preliminary reports for clinicians to quickly verify and act upon – significantly improving response times and technology also flags suspected strokes in patients that may not show traditional clinical signs, such as speech problems or a droopy face or means patients can receive potentially life-saving treatments its implementation at Dudley Group NHS Foundation Trust in May 2024, the technology has meant patients were able to be diagnosed within 40-60 minutes, which is up to 1 hour faster than diagnoses without AI. The government is planning to roll out the use of AI across the country as part of the NHS's shift from analogue to digital systems, a 10-year plan called the Plan for Change. Kinnock said: "Artificial intelligence and digital tech are central to our 10 year health plan, helping patients be seen faster to improve outcomes so they can get home sooner." Follow BBC Birmingham on BBC Sounds, Facebook, X and Instagram.
Reuters
9 hours ago
- Reuters
India's Apollo Hospitals to double AI investments, beats profit estimate
HYDERABAD, Aug 12 (Reuters) - India's Apollo Hospitals Enterprise ( opens new tab plans to double its investment in artificial intelligence capabilities over the next two to three years, its CEO said, after the company beat first-quarter profit estimates on higher patient volume. The hospital chain already uses AI tools in diagnosis to read X-rays, scan reports and also in endoscopy - a medical procedure to examine the inside of the body using a camera, CEO Madhu Sasidhar told Reuters on Tuesday. Many large private hospital chains in India, like their western counterparts, are investing in AI capabilities to improve patient diagnosis and decisions related to medical procedures, among others uses. Apollo recently developed technology to read existing scan reports and predict the risk of liver fibrosis in the future, Sasidhar said. "We are also bringing some other new generation agentic AI-type tools," he said. He did not quantify the size of Apollo's existing investment in AI. Apollo, headquartered in the south Indian city of Chennai, partnered with Microsoft (MSFT.O), opens new tab earlier this year to develop AI-based tools to be used in healthcare. Some of them are in early stages of testing, Sasidhar said. Indian hospital chains such as Apollo and Manipal have also been increasing their bed count for a larger share of the market, including through acquisitions of smaller hospital operators. Apollo said it is on track to add 4,370 beds over the next 3-4 years through acquisition, new hospitals and expansion of existing facilities. Its overall bed capacity is currently more than 10,000. The company's consolidated net profit rose 41.8% to 4.33 billion rupees ($49.40 million) for April-June, beating estimates of 3.86 billion rupees, according to data compiled by LSEG. While its overall occupancy rate dipped from last year, in-patient volume grew 3% and average revenue per in-patient increased by 9%, according to Apollo. Quarterly total revenue rose 15% to 58.42 billion rupees, beating estimates of 57.44 billion rupees. The company said it expects double-digit revenue growth for the current financial year. ($1 = 87.6520 Indian rupees)
Telegraph
14 hours ago
- Telegraph
Students fast tracked for autism diagnosis while children wait years
University students will be fast-tracked for autism diagnosis while children continue to wait years, The Telegraph can reveal. Students will be taken out of the regular local services amid surging referrals for young people, according to a trial at University College London starting in the upcoming academic year. Those still on the current waiting lists will still have to wait several years while students use the dedicated service. The NHS is providing £80,000 in funding to UCL, which is setting up a first-of-its-kind autism clinic to focus solely on students. The university-specific NHS clinic will investigate if the approach improves wait list times for both the general population as well as students during the course of the project from October 2025 until November 2026. Officials have said university students pose a 'specific challenge to the dynamics of adult waiting lists' because students can spend longer waiting for an appointment than the length of a degree. This serves to inflate waiting times for the general public in the neighbouring area as well as failing the student, officials say. There has been a 15-fold increase in the number of 18-24 year-olds seeking an appointment for an autism diagnosis since 2019, official data show. Demand for specialist clinics has soared since the Covid-19 pandemic as a result of increased awareness of autism symptoms, often driven by social media. The huge waiting lists mean people often wait several years to be seen by a clinician and get a diagnosis. This overburdening of autism services is forcing individuals with profound autism who require 24/7 care, including non verbal people, to suffer serious delays to their treatment with lifelong ramifications. In the contract between the NHS England and UCL, officials wrote: 'Removing student populations from local specialist autism teams could positively impact the waiting list.' A recent report found that almost a third of self-harm and suicide cases among university students involve neurodiverse individuals, including those with ADHD and autism Autism waiting lists have ballooned in recent years for all ages but most noticeably in under-25s. Telegraph analysis reveals that there were more than a quarter of a million people awaiting an appointment for a diagnosis in March 2025, the most recent available data, up from 17,400 in April 2019. Almost 75,000 children under 10 are on the waiting list, up more than 12-fold in six years from less than 6,000. There are almost 91,000 people between 10 and 25 currently awaiting a referral, up 12-fold from 7,700 pre-pandemic. In contrast, there are just 735 over-65s on the waiting list. However, this is up more than 11-fold itself from just 65 in 2019. An NHS England spokesman told The Telegraph: 'Backed by NHS funding, University College London is trialling a first-of-its-kind dedicated autism clinic and assessment referral pathway for university students. 'The aim is to test whether separating students from the mainstream waiting list leads to faster diagnosis and better support during the often-challenging transition to higher education. 'The project will also identify ways to improve how autistic and neurodivergent students are supported during university, as well as looking for ways to improve NHS services for autistic people more generally.' The system will only be open to UCL students as part of the pilot programme. A UCL spokesman said: 'The project has a number of aims including to pilot and evaluate a referral pathway for UCL students, so that if they suspect they are autistic, they can get a timely assessment at UCL. 'Given current waiting lists in NHS adult services, some people needing autism assessment at university cannot get their assessment until after they graduate.' Other goals of the project are to improve support that can be offered to autistic students and also improve training to clinicians. The UCL spokesman added: 'It is intended that this research will generate a range of new ideas for improving the effectiveness and efficiency of autism services, that can be adopted in settings across the country, such as NHS autism assessment clinics and general mental health services. 'This has the potential to contribute to improvements in the quality of services and waiting times nationally.' 'Diagnosis can be lifesaving' Mel Merritt, the head of policy and campaigns at the National Autistic Society, said: 'This trial is an opportunity to provide faster diagnosis and better support for autistic university students. 'An autism diagnosis is often life changing and can be lifesaving. University is an important transitional time for many young autistic people and it's important they receive a timely diagnosis so they can get the right support. 'Nine in 10 people wait longer than the recommended 13 weeks and the average wait time is more than 14 months, with many waiting years. 'Without a diagnosis, avoidable crises can develop and, while it shouldn't be the case, often support isn't provided until someone has a diagnosis. At school, this means children and young people miss out on years of their education. 'The Government must provide urgent funding for diagnosis services across the country to end this worsening crisis, and make sure autistic people and their families get the support they need.'
